3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Conditions
Breast Neoplasms
3498
Neoplasms
2739
Prostatic Neoplasms
1583
Colorectal Neoplasms
1247
Lung Neoplasms
1188
Motor Activity
766
Head and Neck Neoplasms
621
Pancreatic Neoplasms
601
Colonic Neoplasms
586
Uterine Cervical Neoplasms
567
Carcinoma, Non-Small-Cell Lung
560
Carcinoma, Hepatocellular
558
Rectal Neoplasms
516
Stomach Neoplasms
493
Brain Neoplasms
436
Anxiety Disorders
401
Ovarian Neoplasms
399
Pain
376
Esophageal Neoplasms
347
Neoplasm Metastasis
340
Polycystic Ovary Syndrome
339
Fatigue
324
Urinary Bladder Neoplasms
314
Precursor Cell Lymphoblastic Leukemia-Lymphoma
303
Melanoma
298
Depression
286
Multiple Myeloma
283
Endometrial Neoplasms
263
Lymphoma
258
Hematologic Neoplasms
251
Interventions
Radiotherapy, Intensity-Modulated
1
Nimorazole
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
OTHER
×
DNA Virus Infections
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled
NCT05453006
2025-07-10
Isbaar
University of Minnesota
Phase NA
Completed
3,367 enrolled
8 charts